The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia
Fazal-i-Akbar Danish,1 Saeeda Yasmin21James Paget University Hospital, Great Yarmouth, Norfolk, United Kingdom; 2Shifa International Hospital, Islamabad, PakistanAbstract: Eltrombopag is a 2nd generation thrombopoietin-receptor agonist. It binds with the thrombopoietin-receptors found on the surface...
Guardado en:
Autores principales: | Danish FA, Yasmin S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29cea24ddb364303ac2f984376a6d7ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ending hepatitis C in the United States: the role of screening
por: Coffin PO, et al.
Publicado: (2014) -
Novel drugs in the management of difficult-to-treat hepatitis C genotypes
por: Cartwright EJ, et al.
Publicado: (2013) -
Selected biochemical and hematological abnormalities in Nigerians with human immunodeficiency virus and hepatitis C virus coinfection
por: Nwokediuko SC, et al.
Publicado: (2011) -
Hepatitis C infection in Egypt: prevalence, impact and management strategies [Corrigendum]
por: Gomaa A, et al.
Publicado: (2017) -
Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus
por: Bruno S, et al.
Publicado: (2011)